Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Helix, Recursion Pharmaceuticals Partner To Drive Drug Discovery Innovation Through Clinico-Genomic Data

Author: Benzinga Newsdesk | June 24, 2024 09:03am

Access to Helix's large-scale clinico-genomic data to drive creation and training of AI models

Helix, a leading population genomics company and provider of precision medicine genomics solutions, today announced a groundbreaking multi-year agreement with Recursion Pharmaceuticals (NASDAQ:RXRX), a leading clinical-stage TechBio company decoding biology to industrialize drug discovery.

Posted In: RXRX